Early research (Phase 1)Study completedNCT00055705What this trial is testingPV701 in Treating Patients With Advanced or Recurrent Peritoneal CancerWho this might be right forCancer Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00004139What this trial is testingGemcitabine Plus Docetaxel or Irinotecan in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung CancerWho this might be right forLung Cancer Alliance for Clinical Trials in Oncology 80
Early research (Phase 1)Study completedNCT01522820What this trial is testingVaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid TumorsWho this might be right forAnaplastic AstrocytomaAnaplastic OligoastrocytomaAnaplastic Oligodendroglioma+62 more Roswell Park Cancer Institute 18
Early research (Phase 1)WithdrawnNCT00017537What this trial is testingVaccine Therapy in Treating Patients With Metastatic or Recurrent CancerWho this might be right forBreast CancerGastric CancerLung Cancer+2 more University of Alabama at Birmingham
Testing effectiveness (Phase 2)Study completedNCT00118183What this trial is testingDocetaxel With Either Cetuximab or Bortezomib as First-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung CancerWho this might be right forAdenocarcinoma of the LungAdenosquamous Cell Lung CancerLarge Cell Lung Cancer+5 more National Cancer Institute (NCI) 62
Large-scale testing (Phase 3)Ended earlyNCT04588246What this trial is testingComparing Whole Brain Radiotherapy Using a Technique That Avoids the Hippocampus to Stereotactic Radiosurgery in Patients With Cancer That Has Spread to the Brain and Come Back in Other Areas of the Brain After Earlier Stereotactic RadiosurgeryWho this might be right forAnatomic Stage IV Breast Cancer AJCC v8Metastatic Lung Non-Small Cell CarcinomaMetastatic Lung Small Cell Carcinoma+9 more NRG Oncology 19
Testing effectiveness (Phase 2)Study completedNCT00430261What this trial is testingPhase II Trial of Sunitinib in BAC or Never-Smokers With Any Lung AdenocarcinomaWho this might be right forLung CancerAdenocarcinoma Swedish Medical Center 20
Testing effectiveness (Phase 2)Study completedNCT00293280What this trial is testingLomustine in Treating Patients With Stage III or Stage IV Non-Small Cell Lung CancerWho this might be right forLung Cancer Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 42
Testing effectiveness (Phase 2)UnknownNCT01497041What this trial is testingA Phase II Clinical Trial of Docetaxel, Oxaliplatin Combination Chemotherapy in Patients With Stage IIIB/IV Non-adenocarcinoma, Non-small Cell Lung Cancer (NSCLC) as Second-line TreatmentWho this might be right forCarcinoma, Non-Small-Cell LungCarcinoma, SquamousCarcinoma, Large Cell Korean South West Oncology Group 35
Early research (Phase 1)Study completedNCT00049296What this trial is testingThalidomide and Docetaxel in Treating Patients With Advanced CancerWho this might be right forCancer Case Comprehensive Cancer Center 26
Not applicableStudy completedNCT01160705What this trial is testingBiomarkers of Response to Taxotere in HRPC. ICORG 08-08, V2Who this might be right forMetastatic CancerProstate Cancer Cancer Trials Ireland 73
Early research (Phase 1)Study completedNCT02206334What this trial is testingStereotactic Body Radiation Therapy in Treating Patients With Metastatic Breast Cancer, Non-small Cell Lung Cancer, or Prostate CancerWho this might be right forMale Breast CarcinomaProstate AdenocarcinomaRecurrent Breast Carcinoma+5 more NRG Oncology 42
Testing effectiveness (Phase 2)Study completedNCT01935336What this trial is testingStudy of Ponatinib in Patients With Lung Cancer Preselected Using Different Candidate Predictive BiomarkersWho this might be right forAdenocarcinoma of the LungExtensive Stage Small Cell Lung CancerLimited Stage Small Cell Lung Cancer+5 more University of Colorado, Denver 171
Testing effectiveness (Phase 2)Study completedNCT00077415What this trial is testing3-AP and Gemcitabine as Second-Line Therapy in Treating Patients With Stage III or Stage IV Recurrent Non-Small Cell Lung CancerWho this might be right forLung Cancer Cancer Therapeutics Research Group 31
Early research (Phase 1)Study completedNCT01155258What this trial is testingTemsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid TumorsWho this might be right forExtensive Stage Small Cell Lung CancerHereditary ParagangliomaMale Breast Cancer+45 more University of Southern California 19
Testing effectiveness (Phase 2)Study completedNCT01218516What this trial is testingA Safety and Efficacy Study of Farletuzumab in Participants With Adenocarcinoma of the LungWho this might be right forAdenocarcinoma of the Lung Morphotek 130
Early research (Phase 1)Study completedNCT00734890What this trial is testingVandetanib and Bevacizumab in Treating Patients With Advanced Solid Tumors or LymphomaWho this might be right forLung CancerLymphomaLymphoproliferative Disorder+2 more National Institutes of Health Clinical Center (CC) 18
Not applicableEnded earlyNCT00904514What this trial is testingStudy of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical TrialWho this might be right forCancer National Institutes of Health Clinical Center (CC) 241
Testing effectiveness (Phase 2)Ended earlyNCT00955305What this trial is testingPaclitaxel, Carboplatin, and Bevacizumab With or Without Cixutumumab in Treating Patients With Stage IV or Recurrent Non-small Cell Lung CancerWho this might be right forLarge Cell Lung CarcinomaLung AdenocarcinomaRecurrent Non-Small Cell Lung Carcinoma+2 more National Cancer Institute (NCI) 175
Testing effectiveness (Phase 2)Study completedNCT00454194What this trial is testingPemetrexed Disodium With or Without Sorafenib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerWho this might be right forLung Cancer Alliance for Clinical Trials in Oncology 110